Medical Implants Company Investment Opportunity in Haifa, Israel

- The company creates human bone tissue to help out patients with bone fractures or spine instability. As it uses their own bone cells and blood components, the product is tailored to a specific patient. Since this product is personalized for each patient, it is not rejected by the patient's body.

- Our product is currently in its early stages. We intend to develop the most efficient and safe method of generating bone in the laboratory, which will be customized for implantation in a specific patient.

- We have a method for experimental bone production which is unique because it combines several elements that have never been combined before, namely self-human bone cells seeded on inorganic matrix, cultured in media containing self-blood serum, and exposed to mechanical stimulation by vibration in a small spectrum of optimal frequency and displacement parameters of the movement.

- There are no revenue figures as the project in the R&D stage. We have spent the last 10 years in research, product will be ready to launch in the next 4 years.

- World market size of bone grafting material is above USD 10 billion.

We are working on developing human bone tissue for clinical use as a bone graft.

The only assets owned by the company are patents.

We do not own a proper facility yet.